Blog Posts
Cancer Symposium
Photo taken from Oncology Brothers/X

Nivo/Gem/Cis now FDA Oncology approved for 1L metastatic bladder cancer based on CM901 – Oncology Brothers

Oncology Brothers made the following post on X:

“Nivo/Gem/Cis now FDA Oncology approved for 1L metastatic bladder cancer based on CM901:

  • Improved OS w/ Nivo (HR 0.78) 21.7mos Vs 18.9mos
  • ≥ Gr3 AEs in 62% Vs 52%
  • New Option (if a patient is not a candidate for EV302)”

Nivo/Gem/Cis now FDA Oncology approved for 1L metastatic bladder cancer based on CM901 - Oncology Brothers

Source: Oncology Brothers/X

cancer OncoDaily Oncology Oncology Brothers Research